Form 4: Health Catalyst CFO Jason Alger Reports Acquisition of Common Stock and Restricted Stock Units

Sentiment:

SEC Form 4


Jason Alger, CFO of Health Catalyst, reports the acquisition of common stock and restricted stock units, increasing his beneficial ownership in the company.

Summary

  • On February 20, 2025, Jason Alger, the Chief Financial Officer of Health Catalyst, Inc., reported acquiring 181,000 restricted stock units (RSUs) and 11,950 performance-based restricted stock units (PRSUs).
  • The RSUs were granted under the company's 2019 Stock Option and Incentive Plan.
  • 33.33% of the RSUs will vest on December 1, 2025, with the remaining 66.67% vesting in 8 equal quarterly installments.
  • The PRSUs were awarded based on the company's performance criteria for the fiscal year ended December 31, 2024.
  • Each RSU and PRSU represents a contingent right to receive one share of Health Catalyst's common stock.
  • Following these transactions, Alger's total beneficial ownership in Health Catalyst's common stock is 279,662 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard executive compensation practices and indicates that the company met certain performance criteria, which is a positive signal.

Positives

  • The award of PRSUs indicates that Health Catalyst met certain performance criteria for the fiscal year ended December 31, 2024.
  • The vesting schedule of the RSUs incentivizes long-term commitment from the CFO.

Future Outlook

The vesting schedule of the RSUs suggests a continued commitment from the CFO to the company's long-term performance.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with those of shareholders.

Stakeholder Impact

  • The increased ownership stake of the CFO could align his interests more closely with those of shareholders.
  • Employees may view the awarding of PRSUs positively, as it reflects the company's achievement of performance goals.

Key Dates

DateDescription
02/20/2025Date of transaction: Acquisition of RSUs and PRSUs.
12/01/2025First vesting date for 33.33% of the RSUs.
12/31/2024Fiscal year end for performance criteria related to PRSUs.
02/24/2025Date of signature for the Form 4 filing.

Keywords

Health Catalyst, Jason Alger, CFO, restricted stock units, RSUs, performance-based restricted stock units, PRSUs, beneficial ownership, Form 4, HCAT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.